Orchid Pharma shareholding pattern

ORCHPHARMA

HealthcareMid

755.65

7.40 (0.99%)
Last updated on 18 Aug, 2025 | 15:30 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Orchid Pharma Shareholding Pattern

  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2024-25
  • 2025-26
  • 2023-24
Total Promoters
Segment
Percent

Total Promoters

69.84%

Mutual Fund

17.46%

Insurance

0.85%

Foreign Institutional Investors

2.53%

Domestic Institutional Investors

0.68%

Retail

8.64%

Others

0%

Total Promoters
MAR '24
69.84%
JUN '24
69.84%
SEP '24
69.84%
DEC '24
69.84%

Orchid Pharma FAQs

As of 08-2025, the promoter shareholding in Orchid Pharma stands at 69.84% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Orchid Pharma is 1.39% and 0.72% respectively.

The retail shareholding of the Orchid Pharma is 9.34%.

Changes in shareholding patterns of Orchid Pharma can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Orchid Pharma are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.